Viridian Therapeutics, Inc.
VRDN
$23.03
-$0.14-0.60%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 981.53M | 762.18M | 874.65M | 490.90M | 563.36M |
| Total Receivables | 75.00M | -- | -- | 70.00M | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 24.74M | 22.56M | 19.58M | 11.01M | 15.39M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.08B | 784.74M | 894.23M | 571.91M | 578.75M |
|
|
|||||
| Total Current Assets | 1.08B | 784.74M | 894.23M | 571.91M | 578.75M |
| Net Property, Plant & Equipment | 4.85M | 3.39M | 3.65M | 3.71M | 3.07M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 10.00M | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.11M | 888.00K | 1.54M | 1.52M | 506.00K |
| Total Assets | 1.10B | 789.02M | 899.42M | 577.14M | 582.32M |
|
|
|||||
| Total Accounts Payable | 8.65M | 13.31M | 8.68M | 10.06M | 8.52M |
| Total Accrued Expenses | 54.24M | 37.48M | 60.89M | 39.53M | 34.79M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 722.00K | 738.00K | 753.00K | 730.00K | 8.99M |
| Total Finance Division Other Current Liabilities | 181.00K | 274.00K | 367.00K | 372.00K | 288.00K |
| Total Other Current Liabilities | 181.00K | 274.00K | 367.00K | 372.00K | 288.00K |
| Total Current Liabilities | 63.79M | 51.81M | 70.70M | 50.70M | 52.59M |
|
|
|||||
| Total Current Liabilities | 63.79M | 51.81M | 70.70M | 50.70M | 52.59M |
| Long-Term Debt | 242.16M | 50.44M | 49.94M | 20.89M | 12.35M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.85M | 2.18M | 1.90M | 2.58M | 1.74M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 127.33M | 48.59M | 54.72M | -- | 477.00K |
| Total Liabilities | 435.14M | 153.01M | 177.25M | 74.17M | 67.16M |
|
|
|||||
| Common Stock & APIC | 2.14B | 1.95B | 1.93B | 1.53B | 1.51B |
| Retained Earnings | -1.57B | -1.44B | -1.34B | -1.22B | -1.18B |
| Treasury Stock & Other | -1.15M | -558.00K | 447.00K | 363.00K | 69.00K |
| Total Common Equity | 564.07M | 503.95M | 590.11M | 314.09M | 326.28M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 98.02M | 132.06M | 132.06M | 188.89M | 188.89M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 98.02M | 132.06M | 132.06M | 188.89M | 188.89M |
|
|
|||||
| Total Common Equity | 564.07M | 503.95M | 590.11M | 314.09M | 326.28M |
| Total Preferred Equity | 98.02M | 132.06M | 132.06M | 188.89M | 188.89M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 662.10M | 636.01M | 722.17M | 502.97M | 515.17M |
|
|
|||||